NEPTUNE DIGITAL ASSETS CORP
NPPTF
Intchains Group
ICG
Bitdeer Technologies
BTDR
BIGG DIGITAL ASSETS INC
BBKCF
FRMO CORP
FRMO
US Stock MarketDetailed Quotes
GERN Geron
- 3.950
- -0.090-2.23%
Close Dec 3 16:00 ET
- 4.000
- +0.050+1.27%
Post 18:13 ET
2.39BMarket Cap-12343P/E (TTM)
4.020High3.900Low3.13MVolume4.000Open4.040Pre Close12.35MTurnover0.59%Turnover RatioLossP/E (Static)604.50MShares5.34052wk High8.16P/B2.08BFloat Cap1.64052wk Low--Dividend TTM527.58MShs Float75.875Historical High--Div YieldTTM2.97%Amplitude0.750Historical Low3.951Avg Price1Lot Size
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.
Geron Stock Forum
Almost low enough
Geron Corp - Receives $250 Million at Closing, $125 Million in Debt Available
Royalty Pharma to Acquire Royalty Interest in Geron’s Rytelo for $125 Million
Achieved $28.2 million in RYTELO(TM) (imetelstat) net product revenue in first full quarter of sales
Received $250 million in gross proceeds from synthetic royalty and debt financings with Royalty Pharma and Pharmakon Advisors, with access to an additional $125 million in debt
No comment yet